Eastern Cooperative Oncology Group

This study tests whether the drug daratumumab can eliminate leftover leukemia cells in people with T-cell acute lymphoblastic leukemia (T-ALL) whose cancer did not fully respond to chemotherapy. About 20 participants will receive daratumumab injections. The goal is to see if the …

This study looks at whether giving high-dose chemotherapy followed by a transplant of the patient's own stem cells can help people with peripheral T-cell lymphoma who are already in remission stay cancer-free longer. About 294 adults aged 18 to 75 will be randomly assigned to eit…

This study tests whether adding patient navigators and easy-to-understand educational materials helps more Black and Latino cancer patients learn about and enroll in cancer clinical trials. About 500 patients from community oncology clinics will take part. The goal is to make tri…

This study looks at whether allowing young adults (ages 18-39) with various cancers to choose how they report their symptoms and well-being (called patient-reported outcomes, or PROs) leads to better data collection. About 400 participants will be randomly assigned to either a fi…